Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This appears to be a minor platform/documentation update with no visible changes to the trial details or content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows revision v3.6.4, replacing the previous v3.6.3, indicating a minor update to the study record page. This appears to be a backend or formatting update rather than changes to the study details or eligibility criteria.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision label updated to v3.6.3, replacing v3.6.2. This reflects a minor internal update to the study page without altering visible content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays revision v3.6.2, replacing the prior v3.6.0. This indicates a small update to the page template or underlying system without altering study details or data presented.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now communicates that recruitment is closed and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with Intervention/Treatment; the site version updates to v3.6.0, and the older label 'Intervention / Treatment' and revision note v3.5.5 are removed.SummaryDifference0.4%

- Check68 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing Revision: v3.5.4. This appears to be a minor site update rather than a modification of the study details or study results.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.